Mutations that affect the mitochondrial DNA may play a key role in cancers. However, the exact mutations that are involved in cancer are still unknown. Dr Fatimata Mbaye and collaborators, from the University of Dakar in Senegal examined the sequences of two regions of the mitochondrial genome to identify mutations that might serve as biomarkers for early disease diagnosis.

Read more about this work in Research Outreach, or find the original paper at:  doi.org/10.31557/APJCP.2019.20.7.2203